Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(400)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Jun 17, 2022 10:37am
BIOV I GOT MY FILL THANK YOU!! HAPPY FOR THOSE WHO GOT @.095
DANG RIGHT I'M happy as long as the shares are in strong hands and PROGRESS is continuing to move and shareholders are continuing to be informed....my money staying right here until I get what I
...more
(15)
•••
1DoxieDollar
X
View Profile
View Bullboard History
Post by
1DoxieDollar
on Jun 16, 2022 7:46pm
BVX-0918/T cell video
Not sure how to post it here, but the BIOV twitter account has a really cool video from Cambridge Univ that explains how T cells kill tumors. Stimulating T cell response to tumors is
...more
Silvercorp to Acquire Adventus, Creating a Diversified Mining Company
posted May 02, 2024 9:00am by
Adventus Mining Corp.
-
|
Under the terms of the Arrangement Agreement, each holder of the common shares of Adventus will receive 0.1015 of one Silvercorp common share in exchange for each Adventus Share at the effective time of the Transaction. The Exchange Ratio implies consideration of C$0.50 per Adventus Share ...read more
(2805)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jun 15, 2022 2:32pm
Other market .13 buy
13:57:06 U 0.13 0.02 2,000 2 RBC
(400)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Jun 15, 2022 2:14pm
BIOV COME BACK HERE NOW~DATS ME ON BID@.10 FINISH MY FILL!!
PROGRESS...and more progress......that is all I am looking for in this ridiculous market. Any other time our sp would soar on this news. Great Job I see the FDA holding a trophy for us in the near off
...more
(10)
•••
mba123ccu
X
View Profile
View Bullboard History
Comment by
mba123ccu
on Jun 15, 2022 9:11am
RE:News again BVX-0918 Vaccine Process Development
This is a critical stage, if successful hope we can see rapid progress.
(2805)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jun 15, 2022 8:43am
News again BVX-0918 Vaccine Process Development
Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development VANCOUVER, BC, June 15, 2022 /PRNewswire
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 15, 2022 8:00am
New Press Release - Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development
VANCOUVER, BC, June 15, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its clinical study collaborator Hospices Civils de Lyon in France ("HCL") has surgically excised the first ovarian cancer tumors from cancer...
read article.
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jun 11, 2022 8:40pm
Covid testing
https://www.swansonreed.com/inotiv-inc-to-evaluate-biovaxys-covidth/
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jun 10, 2022 12:45pm
Eguity guru
https://equity.guru/2022/06/10/the-millennial-sweet-tooth-sector-roundup-week-10/
(15)
•••
1DoxieDollar
X
View Profile
View Bullboard History
Post by
1DoxieDollar
on Jun 10, 2022 11:34am
Article in France this morning-BIOV
https://www.lequotidiendumedecin.fr/specialites/cancerologie/lyon-fait-le-choix-de-lhaptenisation-pour-un-candidat-developpe-avec-biovaxys
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jun 09, 2022 7:16pm
Interview
https://m.youtube.com/watch?v=xoJk7UC6jns
(2805)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jun 08, 2022 2:35pm
.125 other market bid ask
14:09:51 O 0.125 0.015 5,000 1 Anonymous Ask 0.145 11,500 1 0.14 3,000 1
...more
(2805)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jun 08, 2022 9:46am
Level 2 bid and ask
Ask 0.135 11,000 1 0.13 1,000 1 0.125 1,000 1 0.12 9,000 1 0.115
...more
(10)
•••
mba123ccu
X
View Profile
View Bullboard History
Comment by
mba123ccu
on Jun 08, 2022 8:47am
RE:News Bio-Manufacturing Partner BioElpida Completes Next Phas
"Completion of OVCAR-3 cell banks is another step towards our ability to produce GMP yields of BVX-0918, and brings us closer to our Phase I study in the EU planned for later this year."
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results